The Impact of Hydroxyethyl Starch Use in Deceased Organ Donors on the Development of Delayed Graft Function in Kidney Transplant Recipients: A Propensity-Adjusted Analysis

American Journal of Transplantation

Volumn 15, Issue 8, 2015, Pages 2152-2158

  Patel, M S ^a   Niemann, C U ^b   Sally, M B ^c,d   De La Cruz, S ^c,d   Zatarain, J ^e   Ewing, T ^f   Crutchfield, M ^c   Enestvedt, C K ^d   Malinoski, D J ^c,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e University of Texas Medical Branch School of Medicine   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

donors and donation; donors and donation: donation after brain death (DBD)

Indexed keywords

CREATININE; HETASTARCH; HETASTARCH DERIVATIVE;

ADULT; ARTICLE; CADAVER DONOR; COLD ISCHEMIA; CREATININE BLOOD LEVEL; DELAYED GRAFT FUNCTION; DEMOGRAPHY; GRAFT RECIPIENT; HUMAN; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MIDDLE AGED; OBSERVATIONAL STUDY; ORGAN DONOR; PRIORITY JOURNAL; PROPENSITY SCORE; PROSPECTIVE STUDY; RENAL REPLACEMENT THERAPY; ANIMAL; CAT; DONOR; KIDNEY FUNCTION TEST; KIDNEY TRANSPLANTATION;

ADULT; ANIMALS; CATS; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; TISSUE DONORS;

EID: 84937519971     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13263     Document Type: Article

References (16)

1. Malinoski DJ, Patel MS, Ahmed O, et al., The impact of meeting donor management goals on the development of delayed graft function in kidney transplant recipients. Am J Transplant 2013; 13: 993-1000.
2. Blasco V, Leone M, Antonini F, Geissler A, Albanese J, Martin C,. Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation. Br J Anaesth 2008; 100: 504-508.
3. Wiedermann CJ, Joannidis M,. Accumulation of hydroxyethyl starch in human and animal tissues: A systematic review. Intensive Care Med 2013; 21.
4. Rasmussen KC, Johansson PI, Hojskov M, et al., Hydroxyethyl starch reduces coagulation competence and increases blood loss during major surgery: Results from a randomized controlled trial. Ann Surg 2014; 259: 249-254.
5. Zarychanski R, Abou-Setta AM, Turgeon AF, et al., Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: A systematic review and meta-analysis. JAMA 2013; 309: 678-688.
6. Randell T, Orko R, Hockerstedt K,. Peroperative fluid management of the brain-dead multiorgan donor. Acta Anaesthesiol Scand 1990; 34: 592-595.
7. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P,. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348: 1620-1622.
8. Deman A, Peeters P, Sennesael J,. Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: A retrospective, multicentre analysis. Nephrol Dial Transplant 1999; 14: 1517-1520.
9. Hokema F, Ziganshyna S, Bartels M, et al., Is perioperative low molecular weight hydroxyethyl starch infusion a risk factor for delayed graft function in renal transplant recipients? Nephrol Dial Transplant 2011; 26: 3373-3378.
10. Giral M, Bertola JP, Foucher Y, et al., Effect of brain-dead donor resuscitation on delayed graft function: Results of a monocentric analysis. Transplantation 2007; 83: 1174-1181.
11. Malinoski DJ, Daly MC, Patel MS, Oley-Graybill C, Foster CE 3rd, Salim A,. Achieving donor management goals before deceased donor procurement is associated with more organs transplanted per donor. J Trauma 2011; 71: 990-995; discussion 996.
12. Malinoski DJ, Patel MS, Daly MC, Oley-Graybill C, Salim A,. The impact of meeting donor management goals on the number of organs transplanted per donor: Results from the United Network for Organ Sharing Region 5 prospective donor management goals study. Crit Care Med 2012; 40: 2773-2780.
13. LaValley MP,. Logistic regression. Circulation 2008; 117: 2395-2399.
14. Ohman EM, Granger CB, Harrington RA, Lee KL,. Risk stratification and therapeutic decision making in acute coronary syndromes. JAMA 2000; 284: 876-878.
15. Legendre C, Thervet E, Page B, Percheron A, Noel LH, Kreis H,. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 1993; 342: 248-249.
16. Bernard C, Alain M, Simone C, Xavier M, Jean-Francois M,. Hydroxyethylstarch and osmotic nephrosis-like lesions in kidney transplants. Lancet 1996; 348: 1595.